Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children
Authors:
- Alper SoyluASAlper Soylu
- Eray DirikEDEray Dirik
- 1 August 2000
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 23 (2) , 142-146
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Serum lipids in epileptic children treated with carbamazepine and valproateEuropean Journal of Pediatrics, 1997
- Effects of long‐term treatment with antiepileptic drugs on serum lipid levels in children with epilepsyNeurology, 1995
- Total Cholesterol, High‐Density Lipoprotein Cholesterol, and Triglycerides in Children Receiving Antiepileptic DrugsEpilepsia, 1992
- Serum Bilirubin Levels with Antiepileptic DrugsEpilepsia, 1989
- Mlicrosomal Enzyme Induction, Lipoproteins and AtherosclerosisBasic & Clinical Pharmacology & Toxicology, 1988
- Hepatic Considerations in the Use of Antiepileptic DrugsEpilepsia, 1987
- Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.BMJ, 1985
- The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic childrenNeurology, 1983
- Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatmentScandinavian Journal of Clinical and Laboratory Investigation, 1980
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975